How to Evaluate an Alternative to Kaneka M-721

Translate the reference grade into an approval baseline

Begin with the exact current material, supplier, lot history, addition level, PC or PC/ABS grade, complete formulation and reason for considering a second source. Document the incumbent process window and the properties that control release. The baseline should include not only impact values but also flow, heat response, tensile and flexural behavior, appearance, color, dimensional stability, molding stability and any finished-part drop, assembly or environmental test.

Do not assume the trade name alone describes the customer’s approved system. A current formulation may contain pigments, flame retardants, stabilizers, lubricants, recycled content or other ingredients that change modifier response. Freeze those variables before comparing candidates. Record specimen preparation, conditioning, notch method, temperature and units so that the result can be reproduced and audited.

Review what RC-721 evidence does and does not show

RC-721 has a public product specification, an example batch COA, a grade-specific English TDS, a controlled PC dataset using PC-110 / RC-721 = 95 / 5 and controlled PC/ABS application data in the published 85 / 10 / 4.5 / 0.3 / 0.2 source formulation. The PC dataset reports 745 J/m at 23°C and 648 J/m at -30°C. These results support evaluation planning for the stated formulations.

The evidence does not establish chemical identity with Kaneka M-721, universal interchangeability, a guaranteed dosage or guaranteed performance in a different resin. The example COA describes one identified batch; it is not a promise that every batch will reproduce every numerical result shown. SDS, transport evidence, product specification, application testing and batch COA answer different questions and should remain separate in the qualification file.

Design the side-by-side trial

• Use the same resin and additive lots for the incumbent, RC-721 and unmodified control where practical.
• Match the current commercial addition level first, then use a justified dosage ladder if optimization is required.
• Hold feeding, drying, extrusion, residence time, pellet conditioning, molding and specimen preparation constant.
• Test the complete agreed property set at the required temperatures and retain both favorable and unfavorable results.
• Inspect dispersion, deposits, surface, color and process stability; a strong isolated impact result does not compensate for an unacceptable manufacturing window.

Move from laboratory sample to controlled supply

If RC-721 passes the initial screen, repeat the preferred condition and evaluate representative molded parts. Link the sample label and test report to the RC-721 grade and batch. Request the current TDS, SDS where needed, current or sample COA, packaging information and change-control expectations. For higher-risk applications, confirm performance across more than one commercial-representative lot before authorizing a switch.

Define how incoming lots will be checked and what would trigger requalification. A purchasing description should identify RC-721, approved manufacturer or supply route, packaging, required documents and any agreed acceptance criteria. Preserve a retained sample and the approved formulation revision so that later deviations can be investigated. A successful sample without lot traceability is not a robust second-source approval.

Keep commercial approval separate

Technical approval does not make a public price a firm offer. Review the current indicative price only after the material and addition level are technically acceptable. Confirm quantity, packaging, destination, FOB or CIF basis, current freight, insurance input where applicable, validity and lead time. Final price and CIF require manual confirmation. Compare total compound economics, not only modifier price per metric ton, because dosage, yield, processing stability and qualification risk affect the real cost.

The defensible conclusion is narrow: RC-721 is a comparable grade for evaluation against Kaneka M-721, and it may be approved only if the customer’s documented trial and supply controls pass. Do not claim absolute equivalence, chemical identity or automatic interchangeability. If a required property or document is unavailable, keep the status as needs evidence and retain the incumbent until the gap is closed.

Products for Evaluation and D1 Price Status

Reference price range only. Actual price depends on grade, quantity, destination and current market conditions. Please contact us for today's confirmed CIF quotation.

Controlled Evidence and Related Resources

Frequently Asked Questions